News

Objective We sought to investigate the long-term outcomes of patients who develop immune checkpoint inhibitor (ICI)-induced inflammatory arthritis (IA), to define factors associated with IA ...
Objective To compare the efficacy of an exercise and education programme with open-label placebo given as intra-articular injections of inert saline on pain and function in individuals with knee ...
Objective: To develop a composite score for measurement of disease activity in polymyalgia rheumatica (PMR) and assess its internal and external validity. Methods: A PMR activity score (AS) was ...
OBJECTIVES Cigarette smoking may influence rheumatoid arthritis (RA) disease incidence and may have direct biological effects on the lungs and systemically. This study sought to determine if cigarette ...
Background Rheumatoid arthritis (RA) is one of the commonest autoimmune diseases. It affects about 1% of the population worldwide (1). The prevalence of RA varies widely between different countries (2 ...
POS0155 PERIPHERAL JOINT AND ENTHESIS INVOLVEMENT IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): SYMPTOMS, CLINICAL AND ULTRASONOGRAPHIC FINDINGS ...
Objectives To compare mortality risks in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) and patients with RA without ILD. Design Matched cohort study. Setting The ...
Background Sjögren’s syndrome (SS) is a chronic, systemic autoimmune disease affecting exocrine glands, primarily the salivary and tear glands, with potentially severe manifestations in multiple ...
Osteoarthritis (OA) currently affects over 40 million Europeans, with its associated personal suffering and significant economic burden for health systems set to dramatically escalate in a rapidly ...
OBJECTIVE To analyse the relations between the urinary levels of type II collagen C-telopeptide (CTX-II) and glucosyl-galactosyl pyridinoline (Glc-Gal-PYD)—two newly developed biochemical markers of ...
We describe a patient with polymyalgia rheumatica/giant cell arteritis (PMR/GCA) whose disease was refractory to a reduction in the dose of her glucocorticoid to an acceptable level. Our patient ...
New drugs - new perspectives: clinical and regulatory issues concerning biosimilars ...